Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: NOVARTIS
Woman Max 99 years
NOVARTIS FARMA
Update Il y a 4 ans
A prospective, randomized, multi-center comparative 2-arm trial on efficacy and safety of zoledronic acid every 3-months vs. every 4 weeks beyond approximately 1 year of treatment with zoledronic acid in patients with bone lesions from breast cancer
The primary objective is to determine the efficacy skeletal morbidity rate of Zometa administered every three months versus Zometa given every 4 weeks in patients with bone metastasis from breast ca...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
NOVARTIS FARMA
Update Il y a 4 ans
Study to investigate the current criteria driving re-treatment with ranibizumab upon relapse in patients with visual impairment due to choroidal neovascularization secondary to pathologic myopia
The primary objective of the study is to investigate current criteria driving re-treatment in patients affected by CNV secondary to PM and experiencing a relapse of the disease after the first adminis...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
NOVARTIS FARMA
Update Il y a 4 ans
An 8-week, randomized, double-blind, parallel-group, multicenter study assessing the efficacy and safety of aliskiren 75 mg, 150 mg, and 300 mg in patients 65 years of age with essential hypertension, using 24-hour ABPM, with lisinopril 10 mg as a reference
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
NOVARTIS FARMA
Update Il y a 4 ans
Multicenter, randomized, blinded, placebo controlled, cross over, single dose study to assess the effect of indacaterol (150 �g) versus tiotropium (18 �g) on Inspiratory Capacity in moderate COPD patients
To demonstrate that a single dose of indacaterol 150 μg is non inferior to a single dose of tiotropium 18 μg with regard to the Inspiratory Capacity (IC) peak value (defined as maxim...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
NOVARTIS
Update Il y a 4 ans
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Type 2 Diabetes
The purpose of this study was to evaluate, in patients with Type 2 Diabetes Mellitus, whether Canakinumab can lower Glycosylated hemoglobin / hemoglobin A1c (HbA1c) and/or peak glucose lev...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
NOVARTIS FARMA
Update Il y a 4 ans
A randomised, open label, multicenter study comparing the efficacy and safety of medical treatment with Sandostatin LAR 30 mg administered every 21 days for 6 months with that of Sandostatin LAR 60 mg administered every 28 days for 6 months in acromegalic patients with uncontrolled disease
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
NOVARTIS FARMA
Update Il y a 4 ans
A randomized, double-blind, vehicle-controlled, multicenter trial of topically administered LDE225 cream [0.75% bid] to evaluate clearance of Basal Cell Carcinoma in adult patients with Nevoid Basal Cell Carcinoma Syndrome
The primary objective is: • To demonstrate the superiority of topical LDE225 versus vehicle in terms of treatment success in patients with NBCCS, 4 weeks after LDE225 treatment for 8 weeks or 12 we...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
NOVARTIS FARMA
Update Il y a 4 ans
A study to assess how safe and efficient RLX030 is in pre-eclampsia Uno studio per valutare come RLX030 sia sicuro ed efficace nella pre-eclampsia
Part 1: To assess the maternal, fetal, and neonatal safety and tolerability of RLX030 at three doses and placebo when administered intravenously as infusion for 72 hours to women with pre-eclampsia...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
NOVARTIS
Update Il y a 4 ans
Efficacy and Tolerability of STI571 (Imatinib Mesylate) for the Treatment of Fibrosis in Patients With Systemic Sclerosis
This study will investigate the efficacy and safety of STI571 for the treatment of fibrosis in patients with systemic sclerosis. Other purposes of the study are to investigate whether STI5...
Country
Germany
,
Italy
,
Switzerland
,
United Kingdom
,
United States
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
NOVARTIS FARMA
Update Il y a 4 ans
A randomized, double-masked, active-controlled, multicenter study comparing the efficacy and safety ofranibizumab 0.3 mg and 0.5 mg administered as twodosing regimens in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
1
2
3
4
5
6
7
8
9
10
Next